184 related articles for article (PubMed ID: 11474224)
1. Urinary copper excretion in type 2 diabetic patients with nephropathy.
Ito S; Fujita H; Narita T; Yaginuma T; Kawarada Y; Kawagoe M; Sugiyama T
Nephron; 2001 Aug; 88(4):307-12. PubMed ID: 11474224
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion rate of ceruloplasmin in non-insulin-dependent diabetic patients with different stages of nephropathy.
Yamazaki M; Ito S; Usami A; Tani N; Hanyu O; Nakagawa O; Nakamura H; Shibata A
Eur J Endocrinol; 1995 Jun; 132(6):681-7. PubMed ID: 7788006
[TBL] [Abstract][Full Text] [Related]
3. [Changes in serum and urine ceruloplasmin concentrations in type 2 diabetes].
Qin LX; Zeng X; Huang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):208-11. PubMed ID: 16145917
[TBL] [Abstract][Full Text] [Related]
4. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
5. Glycemic control reverses increases in urinary excretions of immunoglobulin G and ceruloplasmin in type 2 diabetic patients with normoalbuminuria.
Narita T; Fujita H; Koshimura J; Meguro H; Kitazato H; Shimotomai T; Kagaya E; Suzuki K; Murata M; Usami A; Ito S
Horm Metab Res; 2001 Jun; 33(6):370-8. PubMed ID: 11456288
[TBL] [Abstract][Full Text] [Related]
6. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
[TBL] [Abstract][Full Text] [Related]
7. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy.
Karatas A; Turkmen E; Erdem E; Dugeroglu H; Kaya Y
Biomark Med; 2018 Sep; 12(9):953-959. PubMed ID: 30043636
[TBL] [Abstract][Full Text] [Related]
8. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy.
Kin Tekce B; Tekce H; Aktas G; Sit M
Clin Invest Med; 2014 Dec; 37(6):E377-83. PubMed ID: 25618270
[TBL] [Abstract][Full Text] [Related]
10. [The clinical significance of detection of urinary ceruloplasmin in type 2 diabetes].
Shi H; Fang J; Yang Y; Jiang W; Xie J; Li Y; Zhu X
Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):823-5. PubMed ID: 16206672
[TBL] [Abstract][Full Text] [Related]
11. Diurnal changes in urinary excretion of IgG, transferrin, and ceruloplasmin depend on diurnal changes in systemic blood pressure in normotensive, normoalbuminuric type 2 diabetic patients.
Hosoba M; Fujita H; Miura T; Morii T; Shimotomai T; Koshimura J; Yamada Y; Ito S; Narita T
Horm Metab Res; 2009 Dec; 41(12):910-5. PubMed ID: 19670106
[TBL] [Abstract][Full Text] [Related]
12. Serum type IV collagen in diabetic patients at risk for nephropathy.
Cohen MP; Shearman CW; Lautenslager GT
Diabetes Care; 2001 Aug; 24(8):1324-7. PubMed ID: 11473064
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].
Yashima I; Hirayama T; Shiiki H; Kanauchi M; Dohi K
Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of advanced glycation endproducts in patients with type 2 diabetes and various stages of proteinuria.
Turk N; Mornar A; Mrzljak V; Turk Z
Diabetes Metab; 2004 Apr; 30(2):187-92. PubMed ID: 15223992
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
Chuahirun T; Khanna A; Kimball K; Wesson DE
Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
[TBL] [Abstract][Full Text] [Related]
16. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
17. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
18. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes.
Tessari P; Kiwanuka E; Barazzoni R; Vettore M; Zanetti M
Diabetologia; 2006 Aug; 49(8):1955-61. PubMed ID: 16703327
[TBL] [Abstract][Full Text] [Related]
20. Hypertension increases urinary excretion of immunoglobulin G, ceruloplasmin and transferrin in normoalbuminuric patients with type 2 diabetes mellitus.
Ohara N; Hanyu O; Hirayama S; Nakagawa O; Aizawa Y; Ito S; Sone H
J Hypertens; 2014 Feb; 32(2):432-8. PubMed ID: 24256706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
